BR9503468A - Composto composiçao farmacêutica processo para preparaçao do composto seu uso e processo para tratar um animal afetado por ou em risco de contrair uma doença viral ou relacionada - Google Patents
Composto composiçao farmacêutica processo para preparaçao do composto seu uso e processo para tratar um animal afetado por ou em risco de contrair uma doença viral ou relacionadaInfo
- Publication number
- BR9503468A BR9503468A BR9503468A BR9503468A BR9503468A BR 9503468 A BR9503468 A BR 9503468A BR 9503468 A BR9503468 A BR 9503468A BR 9503468 A BR9503468 A BR 9503468A BR 9503468 A BR9503468 A BR 9503468A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- contracting
- viral
- treat
- risk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28189394A | 1994-07-28 | 1994-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9503468A true BR9503468A (pt) | 1996-02-27 |
Family
ID=23079211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9503468A BR9503468A (pt) | 1994-07-28 | 1995-07-27 | Composto composiçao farmacêutica processo para preparaçao do composto seu uso e processo para tratar um animal afetado por ou em risco de contrair uma doença viral ou relacionada |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP0694547B1 (pt) |
JP (1) | JP3090305B2 (pt) |
KR (1) | KR100358626B1 (pt) |
CN (1) | CN1045089C (pt) |
AT (1) | ATE179173T1 (pt) |
AU (1) | AU697107B2 (pt) |
BR (1) | BR9503468A (pt) |
CA (1) | CA2154721C (pt) |
CO (1) | CO4410181A1 (pt) |
CY (2) | CY2180B1 (pt) |
CZ (1) | CZ290511B6 (pt) |
DE (3) | DE69509173T2 (pt) |
DK (1) | DK0694547T3 (pt) |
ES (1) | ES2083348T3 (pt) |
FI (1) | FI112080B (pt) |
GR (2) | GR960300021T1 (pt) |
HK (1) | HK1012339A1 (pt) |
HU (1) | HU216867B (pt) |
IL (1) | IL114735A (pt) |
LU (1) | LU91136I2 (pt) |
MA (1) | MA23631A1 (pt) |
MY (1) | MY114393A (pt) |
NL (1) | NL300071I2 (pt) |
NO (2) | NO312899B1 (pt) |
NZ (1) | NZ272652A (pt) |
PE (1) | PE32296A1 (pt) |
PL (1) | PL180609B1 (pt) |
RU (1) | RU2133749C1 (pt) |
SA (1) | SA95160158B1 (pt) |
TR (1) | TR199500895A2 (pt) |
TW (1) | TW434242B (pt) |
UY (1) | UY24006A1 (pt) |
ZA (1) | ZA956228B (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
US5700936A (en) * | 1996-01-26 | 1997-12-23 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate |
US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
WO1997027198A1 (en) * | 1996-01-26 | 1997-07-31 | F.Hoffmann-La Roche Ag | Process for preparing purine derivatives |
WO1997027194A1 (en) * | 1996-01-26 | 1997-07-31 | F. Hoffmann-La Roche Ag | Process for preparing purine derivatives |
US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
US5869493A (en) * | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
ES2186127T3 (es) * | 1997-02-10 | 2003-05-01 | Medivir Ab | Sintesis de derivados de nucleosidos aciclicos. |
US6184376B1 (en) | 1997-02-10 | 2001-02-06 | Mediver Ab | Synthesis of acyclic nucleoside derivatives |
CZ300757B6 (cs) * | 1997-08-15 | 2009-08-05 | Medivir Ab | Nukleosidové analogy, jako jsou antivirální cinidla obsahující inhibitory retrovirální reverzní transkriptázy a DNA polymerázy viru hepatitidy B (HBV) |
WO1999032490A1 (en) * | 1997-12-19 | 1999-07-01 | Bristol-Myers Squibb Company | Prodrugs of lobucavir and methods of use |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
KR20030015655A (ko) * | 2001-08-17 | 2003-02-25 | 한미약품공업 주식회사 | 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물 |
WO2003091214A1 (en) * | 2002-04-23 | 2003-11-06 | Aventis Pharmaceuticals Inc. | 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo |
EP1552833B1 (en) | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
EP3025718A1 (en) | 2003-01-14 | 2016-06-01 | Gilead Sciences, Inc. | Compositions and methods for combination antiviral therapy |
CA2537132A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Amorphous valganciclovir hydrochloride |
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
CA2580313C (en) * | 2004-07-19 | 2016-03-15 | Biocon Limited | Insulin-oligomer conjugates, formulations and uses thereof |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
ZA200702234B (en) * | 2006-03-21 | 2008-07-30 | Cipla Ltd | Preparation of ester of purine derivatives |
US8173158B2 (en) | 2007-10-12 | 2012-05-08 | Takeda Pharmaceuticals U.S.A., Inc. | Methods of treating gastrointestinal disorders independent of the intake of food |
EP2714691B1 (en) * | 2011-05-31 | 2016-09-07 | Pharmathen S.A. | Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir |
KR102312533B1 (ko) | 2021-02-24 | 2021-10-15 | 주식회사 이웅 | 자동 스패너 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8202626A (nl) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | Derivaten van 9-(2-hydroxyethoxymethyl)guanine. |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
ES8705889A1 (es) * | 1984-12-12 | 1987-06-01 | Syntex Inc | Un metodo para preparar eteres alcaximetilicos y esteres alcoximetilicos de derivados de guananina. |
AP55A (en) * | 1987-08-15 | 1989-09-26 | The Wellcome Foundation Ltd | Therapeutic Acyclic Nucleosides |
CA2005815C (en) * | 1988-12-19 | 1999-08-03 | Wellcome Foundation Limited (The) | Antiviral acyclic nucleoside derivatives |
-
1995
- 1995-07-10 PE PE1995273436A patent/PE32296A1/es not_active IP Right Cessation
- 1995-07-19 AT AT95111319T patent/ATE179173T1/de active
- 1995-07-19 ES ES95111319T patent/ES2083348T3/es not_active Expired - Lifetime
- 1995-07-19 DE DE69509173T patent/DE69509173T2/de not_active Expired - Lifetime
- 1995-07-19 DE DE0694547T patent/DE694547T1/de active Pending
- 1995-07-19 DK DK95111319T patent/DK0694547T3/da active
- 1995-07-19 DE DE2002199032 patent/DE10299032I2/de active Active
- 1995-07-19 EP EP95111319A patent/EP0694547B1/en not_active Expired - Lifetime
- 1995-07-21 TR TR95/00895A patent/TR199500895A2/xx unknown
- 1995-07-26 ZA ZA956228A patent/ZA956228B/xx unknown
- 1995-07-26 MA MA23971A patent/MA23631A1/fr unknown
- 1995-07-26 IL IL114735A patent/IL114735A/en not_active IP Right Cessation
- 1995-07-26 CA CA002154721A patent/CA2154721C/en not_active Expired - Lifetime
- 1995-07-26 NZ NZ272652A patent/NZ272652A/en not_active IP Right Cessation
- 1995-07-26 AU AU27195/95A patent/AU697107B2/en not_active Expired
- 1995-07-26 HU HU9502238A patent/HU216867B/hu unknown
- 1995-07-27 CZ CZ19951939A patent/CZ290511B6/cs not_active IP Right Cessation
- 1995-07-27 BR BR9503468A patent/BR9503468A/pt active Search and Examination
- 1995-07-27 UY UY24006A patent/UY24006A1/es not_active IP Right Cessation
- 1995-07-27 MY MYPI95002156A patent/MY114393A/en unknown
- 1995-07-27 JP JP07190953A patent/JP3090305B2/ja not_active Expired - Lifetime
- 1995-07-27 KR KR1019950022600A patent/KR100358626B1/ko not_active IP Right Cessation
- 1995-07-27 CO CO95033418A patent/CO4410181A1/es unknown
- 1995-07-27 TW TW084107779A patent/TW434242B/zh not_active IP Right Cessation
- 1995-07-27 RU RU95113148A patent/RU2133749C1/ru active
- 1995-07-27 FI FI953592A patent/FI112080B/fi active Protection Beyond IP Right Term
- 1995-07-27 NO NO19952977A patent/NO312899B1/no not_active IP Right Cessation
- 1995-07-27 PL PL95309812A patent/PL180609B1/pl unknown
- 1995-07-27 CN CN95109671A patent/CN1045089C/zh not_active Expired - Lifetime
- 1995-08-14 SA SA95160158A patent/SA95160158B1/ar unknown
-
1996
- 1996-04-30 GR GR960300021T patent/GR960300021T1/el unknown
-
1998
- 1998-12-15 HK HK98113443A patent/HK1012339A1/xx not_active IP Right Cessation
-
1999
- 1999-07-02 GR GR990401760T patent/GR3030678T3/el unknown
-
2000
- 2000-08-10 CY CY0000039A patent/CY2180B1/xx unknown
-
2001
- 2001-11-23 NL NL300071C patent/NL300071I2/nl unknown
-
2003
- 2003-01-10 NO NO2003001C patent/NO2003001I2/no unknown
- 2003-05-21 LU LU91136C patent/LU91136I2/fr unknown
-
2004
- 2004-10-20 CY CY200400003C patent/CY2004003I2/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9503468A (pt) | Composto composiçao farmacêutica processo para preparaçao do composto seu uso e processo para tratar um animal afetado por ou em risco de contrair uma doença viral ou relacionada | |
PT96145A (pt) | Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem | |
PT90662A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados arilmetilenilicos de tiazolidinonas, imidazolidinonas e oxazolidinonas uteis como agentes antialergicos e agentes antiinflamatorios | |
BR9102386A (pt) | Processo para preparacao de um composto,processo e composicao para combate de ervas daninhas e compostos | |
PT99281A (pt) | Processo para a preparacao de hidroximetil (metilenociclopentil) purinas e de hidroximetil (metilenociclopentil) pirimidinas | |
PT96871A (pt) | Processo para a preparacao de compostos 3-arilcarbonil-1h-indol uteis como agentes terapeuticos | |
PT81586B (pt) | Processo para a preparacao de derivados de benzoxazol e benzotiazolamina e de composicoes farmaceuticas que os contem | |
ES2131373T3 (es) | Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico. | |
DK0619296T3 (da) | Phenylalkan(en)syrer med leukotrien B4-antagonistisk aktivitet | |
PT91203A (pt) | Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem | |
PT97407A (pt) | Processo para a preparacao de (r)-9-{2-(fosfono-metoxi)-propil}-guanina | |
MX9300638A (es) | Derivados del acido aminobenzoico. | |
PT92671A (pt) | Processo para a preparacao de ariloxipropanolaminotetralinas farmaceuticamente activas | |
PT90560A (pt) | Processo para a preparacao de uma composicao farmaceutica contendo o derivado de tiazol acido 2-(3-carboxi-1-propiltio)-4-metil-1,3-tiazolil-5-acetico(tiprotimod) para terapia de infeccoes por virus | |
PT98186A (pt) | Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem | |
BR9100769A (pt) | Composto,estereoisomero,formulacao farmaceutica,processo para a preparacao de um composto | |
DK183385A (da) | Apovincaminolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelser som farmaceutika | |
FI941850A (fi) | Uusi yhdiste, joka on leustroduksiini H, sen valmistus ja terapeuttinen käyttö | |
BR9815690A (pt) | Composto, processo para a preparação de qualquer um dos compostos, composição farmacêutica, e, uso do composto de 3-(nafter-1-il-óxi) - pirrolidina, 3-(5,6,7,8 - tetraidro-nafterc-1-il-óxi) - pirrolindina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
HKFN | Application deemed withdrawn (deleted) | ||
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15N | Others concerning applications: notification of judicial decision |
Free format text: INPI-52400.0615/2004 TRIBUNAL REGIONAL FEDERAL DA 2A REGIAO 13A VARA FEDERAL DO RIO DE JANEIRO PROCESSO:NO0506840-58.2004.4.02.5101 APELANTE: F HOFFMANN LA ROCHE AG E OUTRO APELADO: F HOFFMANN LA ROCHE AG E OUTROS DECISAO: IMPROCEDENTE O PEDIDO DA INICIAL E CONCLUINDO PELO INDEFERIMENTO DO PEDIDO DE PATENTE DE INVENCAO PI 9503468-4 DE TITULO ?COMPOSTO, COMPOSICAO FARMACEUTICA, PROCESSO PARA PREPARACAO DO COMPOSTO, SEU USO, E PROCESSO PARA TRATAR UM ANIMAL AFETADO POR, OU SEM RISCO DE CONTRAIR, UMA DOENCA VIRAL OU RELACIONADA?, POR NAO PREENCHER OS REQUISITOS LEGAIS DE ATIVIDADE INVENTIVA E DE SUFICIENCIA DESCRITIVA. |